Clinical Trial Update: Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia [Phase 2]

View source ↗

Summary

Phase 2 trial of BI 6727 (volasertib) as monotherapy or with cytarabine in acute myeloid leukemia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BI 6727 (volasertib) (volasertib)
• CYTARABINE (CYTARABINE)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Leukemia, Myeloid, Acute | Phase 2 | Status: COMPLETED | Results posted: 2023-10-03